8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 25, 2018)

Filed October 25, 2018For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K report on October 25, 2018, announcing its financial results for the third quarter ended September 30, 2018. The report primarily serves to include the press release detailing these results. Investors should note that Gilead provides both GAAP and non-GAAP financial information, with management viewing the non-GAAP figures as useful for a deeper understanding of operational performance. A reconciliation of these measures is available in the accompanying press release.

Key Highlights

  • 1Gilead Sciences announced third-quarter 2018 financial results on October 25, 2018, via an 8-K filing.
  • 2The filing includes a press release with detailed financial results for the quarter ended September 30, 2018.
  • 3Gilead presented financial information on both a GAAP and a non-GAAP basis.
  • 4Management believes non-GAAP measures offer additional utility to investors for operational and financial planning insights.
  • 5A reconciliation between GAAP and non-GAAP financial information is provided in the press release.
  • 6The information in this 8-K and its exhibit are not deemed 'filed' for purposes of Section 18 of the Exchange Act.

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially report Gilead Sciences, Inc.'s financial results for the third quarter ended September 30, 2018, by including the press release that announced these results.

Yes, Gilead Sciences presented its financial information on both a U.S. Generally Accepted Accounting Principles (GAAP) basis and a non-GAAP basis for the relevant periods.

A reconciliation that explains the differences between Gilead's GAAP and non-GAAP financial information can be found on pages 7, 8, and 9 of the press release filed as Exhibit 99.1 to this 8-K report.

The filing specifies that the information contained within this Form 8-K and its attached exhibit will not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor will it be subject to the liabilities under that section.